Looking to publish in JAIDS Journal of Acquired Immune Deficiency Syndromes? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowJAIDS Journal of Acquired Immune Deficiency Syndromes is a journal focused on HIV/AIDS and related research. It publishes 12 issues per year and lists an Impact Factor of 2.2. The journal highlights clinical science, epidemiology, prevention research, implementation science, critical reviews, letters to the editor, and supplements, and it offers an open access publishing option.
Looking to publish in JAIDS Journal of Acquired Immune Deficiency Syndromes? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
JAIDS Journal of Acquired Immune Deficiency Syndromes accepts the following article types. Click on an article type to view submission instructions.
Basic Science
Clinical Science
Translational Research
Epidemiology
Implementation Science
Prevention Research
Critical Review
Original Articles
Rapid Communications
Brief Reports
Letters To The Editor
Recent Publications
Population Viral Load Suppression and Associated Factors in Tanzania: Findings From 2 Sequential Tanzania HIV Impact Surveys of 2016–2017 and 2022–2023
Abbas Ismail, Prosper Njau, Alice Wang, Alexander Kailembo, Samwel Sumba, Baraka Revocatus, Eliezer Taluka, Mary Mayige, Tepa Nkumbula, Elias Bukundi, Haji Faki Faki, Emilian Karugendo, Fahima Issa, Nyambura Moremi, Malewo Optatus, Geofrey Mchau, Rebecca L. Laws, Divya Patel, Haruka Maruyama, Wafaa El–Sadr, Shannon M. Farley, George Mgomella, Mahesh Swaminathan, Sarah E. Porter, Jerome Kamwela
Reply “Interest in and Preference for Long-Acting Injectable Pre-exposure Prophylaxis Among Men Who Have Sex With Men, Trans* Individuals, and Cisgender Heterosexual Women: A Global Systematic Review and Meta-Analysis”
Haoyi Wang, Johann Kolstee, Marco Gaetani, Liana Aphami, Alejandro Adriaque Lozano, Hanne M. L. Zimmermann, Kai J. Jonas
Evaluating Associations Between Cumulative Use of Chronic Liver Injury-Inducing Antiretroviral Therapy and Hepatocellular Carcinoma, By Chronic Liver Disease Status
Jessie Torgersen, Craig W. Newcomb, Dean M. Carbonari, Christopher T. Rentsch, Tamar H. Taddei, Amy C. Justice, Jason A. Roy, Vincent Lo Re
Men’s preferences for HIV self-test distribution strategies in Uganda: A discrete choice experiment
Shiven Bhardwaj, Jackson Mugisha, Julius Magembe, George Eram, Agnes Nakyanzi, Andrew Mujugira, Enrique M. Saldarriaga, Yilin Chen, Connie Celum, Fern Terris-Presholt, Monisha Sharma
Eligibility and Acceptability of Same-Day HIV Pre-Exposure Prophylaxis Initiation During Emergency Care Encounters in Nairobi, Kenya: A Cross-Sectional Study
O. Agatha Offorjebe, Eric Ochola, Beatrice Ngila, John Kinuthia, Harriet Waweru, David Bukusi, Janet Sugut, Peter Munene, Sankei Pirirei, Philemon Kimathi, Susan Ruturi, Daniel K. Ojuka, Victoria E. Hippen, Doha Maaty, Krish Shah, Joseph G. Rosen, Rose Bosire, Michael J. Mello, Carey Farquhar, Adam R. Aluisio
Frequently asked questions
How long does it take to publish?
Rapid Communications will normally be published within 8 weeks of acceptance. The editorial office will acknowledge receipt of the manuscript via e-mail. Authors reviewing Rapid Communications proofs are expected to return corrections within 24 hours of receipt.
Reformat to JAIDS Journal of Acquired Immune Deficiency Syndromes using Livewrite PremiumIs a cover letter required?
A cover letter is requested for Rapid Communications to explain why the paper merits special attention.
Reformat to JAIDS Journal of Acquired Immune Deficiency Syndromes using Livewrite PremiumWhat are the publication costs?
Hybrid open access is available with an APC charged on acceptance and payable within 30 days. Eligible corresponding authors at participating institutions may receive a $0.00 APC under read-and-publish agreements.
Reformat to JAIDS Journal of Acquired Immune Deficiency Syndromes using Livewrite Premium